- Exchange: ASE
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
CSL Ltd+ Add to Watchlist
CSL:AU67.6800 AUD 0.1500 0.22%
As of 02:11:03 ET on 04/17/2014.
Company Profile for CSL Ltd (CSL)
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.
Key Executives for CSL Ltd (CSL)
|John ShineChairman||Paul PerreaultCEO/Managing Director|
|Gordon NaylorChief Financial Officer||Gregory Boss "Greg"Exec VP:Legal/Gen Cnsl|
|Mary SontropExec VP:Manufacturing||Ingolf SieperExec VP:Commercial Operation|
|Jill LeverSenior VP:Human Capital||Edward H Bailey "Ed"Secretary|